Get started
Author

Randolph Marks

Observed names: R S Marks, R.S. Marks
Institution: Mayo Clinic
OpenAlex ID: A5111612221
Wnt signaling pathway pharmacogenetics in non-small cell lung cancer
2014 · D J Stewart, D W Chang, et al. · The Pharmacogenomics Journal · 49
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
2000 · J A Bonner, J A Sloan, et al. · PubMed · 47
Primary cardiac synovial sarcoma
2010 · Muhammad Talukder, Lyle Joyce, et al. · Interactive Cardiovascular and Thoracic Surgery · 16
PDF
MC1923 phase II clinical trial of durvalumab (MEDI4736) and topotecan or lurbinectedin in patients with relapsed extensive-stage small cell lung cancer previously treated with chemotherapy and immunotherapy.
2022 · Konstantinos Leventakos, Anastasios Dimou, et al. · Journal of Clinical Oncology · 4
101 The impact of surgical adjuvant thoracic radiation therapy for non-small cell lung cancer patients with mediastinal nodal involvement
1996 · T.E. Sawyer, J.A. Bonner, et al. · International Journal of Radiation Oncology*Biology*Physics · 4
High-quality basic care and support needed in lung cancer survivors.
2012 · Ping Yang, Roberto P. Benzo, et al. · Journal of Clinical Oncology
Abstract LB-186: Genetic variants and risk of lung cancer in never-smokers: A genome-wide association study
2010 · Yafei Li, Chau-Chyun Sheu, et al. · Cancer Research
Case report - Cardiac general Primary cardiac synovial sarcoma
2010 · Muhammad Talukder, Lyle Joyce, et al.
A phase II study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancer.
2002 · Randolph Marks, Suresh Nair · Lung Cancer
2143 Daily etoposide and cisplatin during thoracic radiotherapy for patients with locally advanced non-small cell lung cancer
1997 · J.A. Bonner, S. Frytak, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 10
Citation count: 120
H-index: 4
I10-index: 3
Year
Topic
Type